Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.95283325
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

26.41 0.56 (2.17%)

83.40% Gain from 52W Low

967.5K

XNAS Volume

XNAS 03 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.3 / 100

Technically Bullish

70.8 / 100

1Yr Price target upside is 113%

12 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

83.40% Gain from 52W Low

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart